New targeted therapy shows promising early results in advanced pancreatic cancer

An investigational targeted therapy designed to artifact 1 of the astir communal familial drivers of pancreatic crab has shown promising aboriginal results erstwhile combined with modular first-line chemotherapy, according to probe presented contiguous astatine the ESMO Gastrointestinal Cancers Congress 2026.